Evidence map›Paper›PMID 27441756›Full record

ArticlePloS one2016

Feasibility of Human Amniotic Fluid Derived Stem Cells in Alleviation of Neuropathic Pain in Chronic Constrictive Injury Nerve Model.

Chien-Yi Chiang, Shih-An Liu, Meei-Ling Sheu, Fu-Chou Chen, Chun-Jung Chen, Hong-Lin Su, Hung-Chuan Pan

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Stem cells and pain.World journal of stem cells · 2023
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Hydrogen-Rich Saline Activated Autophagy via HIF-1BioMed research international · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Chien-Yi ChiangInstitute of Biomedical Sciences, National Chung-Hsing University, Taichung, Taiwan.
Shih-An LiuFaculty of Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan.
Meei-Ling SheuInstitute of Biomedical Sciences, National Chung-Hsing University, Taichung, Taiwan.
Fu-Chou ChenDepartment of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan.
Chun-Jung ChenDepartment of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan.
Hong-Lin SuInstitute of Life Sciences, National Chung-Hsing University, Taichung, Taiwan.
Hung-Chuan PanDepartment of Neurosurgery, Taichung Veterans General Hospital, Taichung, Taiwan.
National Chung Hsing University · TWTaichung Veterans General Hospital · TWNational Taipei University · TWNational Yang Ming Chiao Tung University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe neurobehavior of neuropathic pain by chronic constriction injury (CCI) of sciatic nerve is very similar to that in humans, and it is accompanied by a profound local inflammation response. In this study, we assess the potentiality of human amniotic fluid derived mesenchymal stem cells (hAFMSCs) for alleviating the neuropathic pain in a chronic constriction nerve injury model. METHODS AND

methodsThis neuropathic pain animal model was conducted by four 3-0 chromic gut ligatures loosely ligated around the left sciatic nerve in Sprague-Dawley rats. The intravenous administration of hAFMSCs with 5x105 cells was conducted for three consecutive days.

resultsThe expression IL-1β, TNF-α and synaptophysin in dorsal root ganglion cell culture was remarkably attenuated when co-cultured with hAFMSCs. The significant decrease of PGP 9.5 in the skin after CCI was restored by administration of hAFMSCs. Remarkably increased expression of CD 68 and TNF-α and decreased S-100 and neurofilament expression in injured nerve were rescued by hAFMSCs administration. Increases in synaptophysin and TNF-α over the dorsal root ganglion were attenuated by hAFMSCs. Significant expression of TNF-α and OX-42 over the dorsal spinal cord was substantially attenuated by hAFMSCs. The increased amplitude of sensory evoked potential as well as expression of synaptophysin and TNF-α expression was alleviated by hAFMSCs. Human AFMSCs significantly improved the threshold of mechanical allodynia and thermal hyperalgesia as well as various parameters of CatWalk XT gait analysis.

conclusionHuman AFMSCs administration could alleviate the neuropathic pain demonstrated in histomorphological alteration and neurobehavior possibly through the modulation of the inflammatory response.

Indexed as

Stem Cell TransplantationAmniotic FluidAnimalsBehavior, AnimalCells, CulturedChronic DiseaseConstrictionDisease Models, AnimalEvoked Potentials, SomatosensoryFeasibility StudiesGaitHumansHyperalgesiaInflammationInterleukin-1betaNerve RegenerationInterleukin-1betaSynaptophysinTumor Necrosis Factor-alphaUbiquitin ThiolesteraseUCHL1 protein, rat

Identifiers

PMID27441756
PMCPMC4956194
OpenAlexW2495998573

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.